Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis

被引：3

作者：

Breneman, Alyssa N. ^{[1
]}

Eber, Ariel E. ^{[2
]}

Haque, Hoosna ^{[3
]}

Levine, Libby ^{[4
,5
]}

Askanase, Anca ^{[6
]}

Riley, Claire S. ^{[4
,5
]}

Pomeranz, Miriam Keltz ^{[7
]}

Hassan, Dahlia ^{[6
]}

Mancebo, Silvia E. ^{[8
]}

Polin, Melanie ^{[9
]}

Melamed, Alexander ^{[10
]}

Bordone, Lindsey A. ^{[2
]}

Rosser, Mary ^{[3
]}

Gockley, Allison ^{[10
]}

Gallitano, Stephanie M. ^{[2
]}

机构：

[1] Columbia Univ, Vagelos Coll Phys & Surg, 161 Ft Washington Ave,12th Flr, New York, NY 10032 USA

[2] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10032 USA

[3] Columbia Univ, Dept Obstet & Gynecol, Div Gynecol, Vagelos Coll Phys & Surg, New York, NY 10032 USA

[4] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA

[5] Columbia Univ, Multiple Sclerosis Ctr, Irving Med Ctr, New York, NY 10032 USA

[6] Columbia Univ, Dept Rheumatol, Irving Med Ctr, New York, NY 10032 USA

[7] NYU, Ronald O Perelman Dept Dermatol, Sch Med, New York, NY USA

[8] Cornell Univ, Dept Dermatol, Weill Med Coll, New York, NY 10021 USA

[9] Columbia Univ, Dept Obstet & Gynecol, Vagelos Coll Phys & Surg, New York, NY 10032 USA

[10] Columbia Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Vagelos Coll Phys & Surg, New York, NY 10032 USA

来源：

JOURNAL OF LOWER GENITAL TRACT DISEASE | 2022年 / 26卷 / 02期

关键词：

pyoderma gangrenosum; vulvovaginal; rituximab; ocrelizumab; intravenous immunoglobulin; side effect;

D O I：

10.1097/LGT.0000000000000661

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ocrelizumab is an anti-CD20 monoclonal antibody treatment for multiple sclerosis (MS).1 Pyoderma gangrenosum (PG) is an inflammatory, ulcerative dermatosis.2 Vulvovaginal PG has rarely been associated with rituximab, another anti-CD20 monoclonal antibody.2 We report a unique case of ocrelizumab-associated vulvovaginal PG. Copyright © 2022 ASCCP.

引用

页码：189 / 191

页数：3

共 14 条

[1] Pyoderma gangrenosum adverse event with Rituximab use: A postmarketing pharmacovigilance analysis [J].

Aggarwal, Pushkar .

DERMATOLOGIC THERAPY, 2020, 33 (02)

[2] Pathophysiology of pyoderma gangrenosum (PG): An updated review [J].

Braswell, Sara F. ;

Kostopoulos, Tassia C. ;

Ortega-Loayza, Alex G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (04) :691-698

[3]

Dixit Shreya, 2015, J Low Genit Tract Dis, V19, pe6, DOI 10.1097/LGT.0000000000000043

[4]

Georgakopoulos Jorge R, 2018, JAAD Case Rep, V4, P979, DOI 10.1016/j.jdcr.2018.09.003

[5]

Maloney Catherine, 2018, JAAD Case Rep, V4, P907, DOI 10.1016/j.jdcr.2018.09.001

[6] Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum A Delphi Consensus of International Experts [J].

Maverakis, Emanual ;

Ma, Chelsea ;

Shinkai, Kanade ;

Fiorentino, David ;

Callen, Jeffrey P. ;

Wollina, Uwe ;

Marzano, Angelo Valerio ;

Wallach, Daniel ;

Kim, Kyoungmi ;

Schadt, Courtney ;

Ormerod, Anthony ;

Fung, Maxwell A. ;

Steel, Andrea ;

Patel, Forum ;

Qin, Rosie ;

Craig, Fiona ;

Williams, Hywel C. ;

Powell, Frank ;

Merleev, Alexander ;

Cheng, Michelle Y. .

JAMA DERMATOLOGY, 2018, 154 (04) :461-466

[7] Pyoderma gangrenosum associated with multiple sclerosis [J].

Mujadzic, Misrad ;

Bierbrauer, David ;

Napolitano, Margaret .

PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (06) :2107-2108

[8] Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis [J].

Sanchez, Isabelle M. ;

Lowenstein, Stefan ;

Johnson, Kelly A. ;

Babik, Jennifer ;

Haag, Carter ;

Keller, Jesse J. ;

Ortega-Loayza, Alex G. ;

Cohen, Jarish ;

McCalmont, Timothy H. ;

Demer, Addison M. ;

Mansh, Matthew D. ;

Hylwa, Sara A. ;

Liu, Jing ;

Shinkai, Kanade .

JAMA DERMATOLOGY, 2019, 155 (01) :79-84

[9] Rituximab Causing Deep Ulcerative Suppurative Vaginitis/Pyoderma Gangrenosum [J].

Selva-Nayagam, Priya ;

Fischer, Gayle ;

Hamann, Ian ;

Sobel, Jack ;

James, Craig .

CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (05) :1-6

[10]

Sotzen Jason R, 2021, JAAD Case Rep, V10, P75, DOI 10.1016/j.jdcr.2021.02.013

← 1 2 →